(Q79546010)
Statements
A phase IB, open-label dose-escalating study of the oral angiogenesis inhibitor PTK787/ZK 222584 (PTK/ZK), in combination with FOLFOX4 chemotherapy in patients with advanced colorectal cancer (English)
A L Thomas
C Bartel
D Laurent
A Henry
M Poethig
J Wang
E Masson
W Steward
U Vanhoefer
11 January 2007